← All companies

ADGM

Adagio Medical Holdings, Inc.

ADGM Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$0.80

+0.34 +73.91%

Key statistics

from XBRL data in SEC filings

Market cap

$17.8M

Revenue (TTM)

$0.00

Net income (TTM)

-$24.4M

EPS (TTM)

$-1.31

P/E ratio

—

Dividend yield

—

Free cash flow

-$19.4M

Cash

$12.9M

Total assets

$39.3M

Gross margin

—

52-week range

$0.36 – $2.58

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-K/A Fiscal year ended 2025-12-31 Jul 13, 2026 8-K Shareholder vote results Jun 16, 2026 8-K Delisting notice or listing-rule failure Jun 12, 2026 8-K Other events May 21, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Other events Apr 27, 2026 8-K Item 5.08 Apr 20, 2026 8-K Other events Apr 8, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release) Mar 27, 2026 8-K Shareholder vote results Dec 16, 2025 8-K Director or officer change Dec 11, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Item 5.08 Oct 24, 2025 8-K Other events Oct 20, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Oct 15, 2025 8-K Other events Oct 10, 2025 8-K Other events Oct 1, 2025 8-K Director or officer change; Regulation FD disclosure Sep 8, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 13, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 8-K Director or officer change Apr 23, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Apr 2, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Director or officer change; Regulation FD disclosure Mar 17, 2025 8-K Director or officer change Mar 4, 2025 8-K Regulation FD disclosure Feb 28, 2025 8-K Terminated a material agreement Feb 5, 2025 8-K Entered a material agreement; Delisting notice or listing-rule failure Jan 6, 2025 8-K Delisting notice or listing-rule failure; Director or officer change Dec 23, 2024 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Dec 16, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K/A Nov 4, 2024 8-K Previously issued financials not reliable Nov 1, 2024